Why did oil prices surge after Israel's strike on Iran?
How will the Nippon Steel-US Steel merger impact the steel industry?
What caused the S&P 500 to drop amid Middle East tensions?
Why is Amazon investing in nuclear power for AWS?
How is AI affecting hiring practices at Chipotle?
What are the implications of Walmart and Amazon exploring stablecoins?
Why was US Senator Alex Padilla forcibly removed from press event?
AstraZeneca taps Chinese biotech in $5.2bn chronic disease research deal
finance.yahoo.com/news/astrazeneca-taps-chinese-biotech-5-161930037.html
In This Article:
AstraZeneca has joined the long list of big pharma companies enlisting the services of Chinese biotechs, signing a deal worth up to $5.2bn with CSPC Pharmaceuticals to research chronic disease drug candidates.
Under the deal, AstraZeneca will pay an upfront fee of $110m,…
This story appeared on finance.yahoo.com, 2025-06-13 16:19:30.